Modified Dendrimer Cross-Linked Collagen-Based Matrices

被引:5
作者
Princz, M. A. [1 ]
Sheardown, H. [1 ]
机构
[1] McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L8, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
Collagen; dendrimers; extracellular matrix; heparin; RECOMBINANT HUMAN COLLAGEN; FIBROBLAST-GROWTH-FACTOR; LINKING; HEPARIN; BIOCOMPATIBILITY; GLUTARALDEHYDE; SCAFFOLDS; IMMOBILIZATION; CROSSLINKING; DEGRADATION;
D O I
10.1163/156856211X612736
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Dendrimer cross-linking has been achieved with pepsin digested over 80% type-I bovine collagen to create strong hydrogels with good cell compatibility. Herein we investigate the use of commercially available collagen-based products with the dendrimer cross-linking technology. Specifically PureCol (R) (PC), a 97% bovine type-I collagen, human collagen (HC) and human extracellular matrix (hECM) were concentrated, and then cross-linked with polypropyleneimine octaamine generation two dendrimers using 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS) chemistry. PC gels with 30 and 20 mg/ml bovine collagen were fabricated, and despite similar concentrations to >80% type-I bovine collagen dendrimer cross-linked gels (CG), PC gels demonstrated increased swelling and decreased stability, as determined with collagenase digestion. The highly purified bovine (PC) and human sourced-collagen (HC) gels were similar in performance, but not as stable as the CG gels, which may correlate to the manufacturer's collagen purification and storage. Finally, the addition of hECM components to PC to create PC-hECM gels, resulted in a looser gel network, compared to heparinized dendrimer crosslinked bovine >80% type-I collagen gels (CHG). However, all collagen-based gels supported 3T3 fibroblast cell growth over 4 days, indicating these gels may be suitable for tissue-engineering applications. (C) Koninklijke Brill NV, Leiden, 2011
引用
收藏
页码:2207 / 2222
页数:16
相关论文
共 56 条
[31]   Collagen fibril surface displays a constellation of sites capable of promoting fibril assembly, stability, and hemostasis [J].
Orgel, J. P. R. O. ;
Antipova, O. ;
Sagi, I. ;
Bitler, A. ;
Qiu, D. ;
Wang, R. ;
Xu, Y. ;
Antonio, J. D. San .
CONNECTIVE TISSUE RESEARCH, 2011, 52 (01) :18-24
[32]   USE OF THE ACYL AZIDE METHOD FOR CROSS-LINKING COLLAGEN-RICH TISSUES SUCH AS PERICARDIUM [J].
PETITE, H ;
RAULT, I ;
HUC, A ;
MENASCHE, P ;
HERBAGE, D .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1990, 24 (02) :179-187
[33]   Preparation and characterization of porous crosslinked collagenous matrices containing bioavailable chondroitin sulphate [J].
Pieper, JS ;
Oosterhof, A ;
Dijkstra, PJ ;
Veerkamp, JH ;
van Kuppevelt, TH .
BIOMATERIALS, 1999, 20 (09) :847-858
[34]   Heparin-modified dendrimer cross-linked collagen matrices for the delivery of basic fibroblast growth factor (FGF-2) [J].
Princz, M. A. ;
Sheardown, H. .
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 2008, 19 (09) :1201-1218
[35]   COLLAGENS - MOLECULAR-BIOLOGY, DISEASES, AND POTENTIALS FOR THERAPY [J].
PROCKOP, DJ ;
KIVIRIKKO, KI .
ANNUAL REVIEW OF BIOCHEMISTRY, 1995, 64 :403-434
[36]   A simplified method for the analysis of hydroxyproline in biological tissues [J].
Reddy, GK ;
Enwemeka, CS .
CLINICAL BIOCHEMISTRY, 1996, 29 (03) :225-229
[37]   PROLONGED RESORPTION OF COLLAGEN SPONGES - VAPOR-PHASE TREATMENT WITH FORMALDEHYDE [J].
RUDERMAN, RJ ;
WADE, CWR ;
SHEPARD, WD ;
LEONARD, F .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1973, 7 (02) :263-265
[38]  
Sachlos E., 2003, European Cells & Materials, V5, P29
[39]   In vivo angiogenesis in normal and portal hypertensive rats: role of basic fibroblast growth factor and nitric oxide [J].
Sieber, CC ;
Sumanovski, LT ;
Stumm, M ;
van der Kooij, M ;
Battegay, E .
JOURNAL OF HEPATOLOGY, 2001, 34 (05) :644-650
[40]   Collagen I but not Matrigel matrices provide an MMP-dependent barrier to ovarian cancer cell penetration [J].
Sodek, Katharine L. ;
Brown, Theodore J. ;
Ringuette, Maurice J. .
BMC CANCER, 2008, 8 (1)